|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1993-9-16
|
|
pubmed:abstractText |
Dyslipoproteinaemia is an important risk factor for cardiovascular disease in uraemic patients on continuous ambulatory peritoneal dialysis (CAPD). Lovastatin is an HMG Coenzyme A reductase inhibitor which is useful in treating non-uraemic patients with hypercholesterolaemia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0004-8291
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
252-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8352699-Female,
pubmed-meshheading:8352699-Humans,
pubmed-meshheading:8352699-Hypercholesterolemia,
pubmed-meshheading:8352699-Hypertriglyceridemia,
pubmed-meshheading:8352699-Lipids,
pubmed-meshheading:8352699-Lovastatin,
pubmed-meshheading:8352699-Male,
pubmed-meshheading:8352699-Middle Aged,
pubmed-meshheading:8352699-Peritoneal Dialysis, Continuous Ambulatory,
pubmed-meshheading:8352699-Single-Blind Method,
pubmed-meshheading:8352699-Uremia
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Effect of lovastatin on serum lipid profile in the treatment of dyslipoproteinaemia in uraemic patients on continuous ambulatory peritoneal dialysis.
|
|
pubmed:affiliation |
Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
